Canada markets closed

Sun Pharmaceutical Industries Limited (SUNPHARMA.NS)

NSE - NSE Real Time Price. Currency in INR
Add to watchlist
1,910.35+20.80 (+1.10%)
At close: 03:29PM IST

Sun Pharmaceutical Industries Limited

Sun House
Plot No. 201 B/1 Western Express Highway Goregaon (East)
Mumbai 400063
India
91 22 4324 4324
https://www.sunpharma.com

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees43,000

Key Executives

NameTitlePayExercisedYear Born
Mr. Dilip Shantilal ShanghviMD & Chairman of the Board60.54MN/A1955
Mr. Aalok Dilip ShanghviExecutive VP, Head of Emerging Markets, Global Generics R&D, Business Devp., and Whole Time Director68.75MN/A1984
Mr. C. S. Muralidharan ICWA, M.ComChief Financial Officer38.89MN/A1963
Mr. Davinder SinghExecutive Vice-President of Global OperationsN/AN/AN/A
Mr. Dheeraj Prasad Sinha BEEVP & Chief Information OfficerN/AN/A1971
Dr. Abhishek SharmaVP, Head of Investor Relations & Strategic ProjectsN/AN/AN/A
Mr. Anoop DeshpandeCompany Secretary & Compliance OfficerN/AN/AN/A
Mr. Kalyanasundaram SubramanianDirector of Corporate Development65.3MN/A1954
Mr. Suresh Kumar RaiChief Human Resources OfficerN/AN/AN/A
Mr. Kirti Wardhaman GanorkarHead of India BusinessN/AN/A1967
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.

Description

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology, neuropsychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It provides APIs for anti-cancers, peptides, steroids, hormones, and immunosuppressant drugs. In addition, the company offers generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, and antiretrovirals medications, as well as over-the-counter products. The company was founded in 1983 and is headquartered in Mumbai, India.

Corporate Governance

Sun Pharmaceutical Industries Limited’s ISS Governance QualityScore as of October 1, 2024 is 3. The pillar scores are Audit: 6; Board: 4; Shareholder Rights: 5; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.